Insights

Gathering insights about Fulcrum Therapeutics…

Similar companies to Fulcrum Therapeutics

Fulcrum Therapeutics Tech Stack

Fulcrum Therapeutics uses 8 technology products and services including SiteCatalyst, Squarespace, WordPress, and more. Explore Fulcrum Therapeutics's tech stack below.

SiteCatalyst
Analytics
Squarespace
Content Management System
WordPress
Content Management System
Google Font API
Font Scripts
Google Maps
Maps
HTTP/3
Miscellaneous
Amazon Web Services
Platform As A Service
Nginx
Web Servers

Media & News

Fulcrum Therapeutics's Email Address Formats

Fulcrum Therapeutics uses at least 1 format(s):

Fulcrum Therapeutics Email Formats	Example	Percentage
FLast@fulcrumtx.com	JDoe@fulcrumtx.com	49%
Last@fulcrumtx.com	Doe@fulcrumtx.com	1%
FLast@fulcrumtx.com	JDoe@fulcrumtx.com	49%
Last@fulcrumtx.com	Doe@fulcrumtx.com	1%

Frequently Asked Questions

Where is Fulcrum Therapeutics's headquarters located?

Fulcrum Therapeutics's main headquarters is located at 26 Landsdowne St Cambridge, Massachusetts 02139 US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Fulcrum Therapeutics's phone number?

You can contact Fulcrum Therapeutics's main corporate office by phone at

+1-617-651-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Fulcrum Therapeutics's stock symbol?

Fulcrum Therapeutics is a publicly traded company; the company's stock symbol is FULC.

What is Fulcrum Therapeutics's official website and social media links?

Fulcrum Therapeutics's official website is fulcrumtx.com and has social profiles on LinkedIn.

How much revenue does Fulcrum Therapeutics generate?

As of September 2024, Fulcrum Therapeutics's annual revenue reached $35M.

What is Fulcrum Therapeutics's SIC code NAICS code?

Fulcrum Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Fulcrum Therapeutics have currently?

As of September 2024, Fulcrum Therapeutics has approximately 86 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Executive Officer: A. S.Chief Operating Officer: M. H.Chief Legal Officer: C. O.. Explore Fulcrum Therapeutics's employee directory with LeadIQ.

What industry does Fulcrum Therapeutics belong to?

Fulcrum Therapeutics operates in the Biotechnology Research industry.

What technology does Fulcrum Therapeutics use?

Fulcrum Therapeutics's tech stack includes SiteCatalystSquarespaceWordPressGoogle Font APIGoogle MapsHTTP/3Amazon Web ServicesNginx.

What is Fulcrum Therapeutics's email format?

Fulcrum Therapeutics's email format typically follows the pattern of . Find more Fulcrum Therapeutics email formats with LeadIQ.

How much funding has Fulcrum Therapeutics raised to date?

As of September 2024, Fulcrum Therapeutics has raised $125M in funding. The last funding round occurred on Jan 17, 2023 for $125M.

When was Fulcrum Therapeutics founded?

Fulcrum Therapeutics was founded in 2016.

Fulcrum Therapeutics

Biotechnology ResearchMassachusetts, United States51-200 Employees

We are a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined diseases in areas of high unmet medical need, with an initial focus on rare diseases.

Community Guidelines: https://bit.ly/3t2xeR9

Company Overview

Headquarters: 26 Landsdowne St Cambridge, Massachusetts 02139 US
Phone number: ✕
Access Insights for Fulcrum Therapeutics and Millions of Other Companies
Sign up for full access to Fulcrum Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-617-651-****
Website: fulcrumtx.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: FULC
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2016
Employees: 51-200

Media & News

Funding & Financials

$125M
Fulcrum Therapeutics has raised a total of $125M of funding over 8 rounds. Their latest funding round was raised on Jan 17, 2023 in the amount of $125M.
$10M$50M
Fulcrum Therapeutics's revenue is in the range of $10M$50M

Funding & Financials

$125M
Fulcrum Therapeutics has raised a total of $125M of funding over 8 rounds. Their latest funding round was raised on Jan 17, 2023 in the amount of $125M.
$10M$50M
Fulcrum Therapeutics's revenue is in the range of $10M$50M

Company Leadership

A. S.
Chief Executive Officer
✕
Access Insights for Fulcrum Therapeutics and Millions of Other Companies
Sign up for full access to Fulcrum Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Fulcrum Therapeutics and Millions of Other Companies
Sign up for full access to Fulcrum Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. H.
Chief Operating Officer
✕
Access Insights for Fulcrum Therapeutics and Millions of Other Companies
Sign up for full access to Fulcrum Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Fulcrum Therapeutics and Millions of Other Companies
Sign up for full access to Fulcrum Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
C. O.
Chief Legal Officer
✕
Access Insights for Fulcrum Therapeutics and Millions of Other Companies
Sign up for full access to Fulcrum Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Fulcrum Therapeutics and Millions of Other Companies
Sign up for full access to Fulcrum Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. F.
Chief Technology Officer And Founding Executive Team Member
✕
Access Insights for Fulcrum Therapeutics and Millions of Other Companies
Sign up for full access to Fulcrum Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Fulcrum Therapeutics and Millions of Other Companies
Sign up for full access to Fulcrum Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
K. H.
Chief People Officer
✕
Access Insights for Fulcrum Therapeutics and Millions of Other Companies
Sign up for full access to Fulcrum Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Fulcrum Therapeutics and Millions of Other Companies
Sign up for full access to Fulcrum Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

K. H.
Chief People Officer
✕
Access Insights for Fulcrum Therapeutics and Millions of Other Companies
Sign up for full access to Fulcrum Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Fulcrum Therapeutics and Millions of Other Companies
Sign up for full access to Fulcrum Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
P. H.
Chief Medical Officer
✕
Access Insights for Fulcrum Therapeutics and Millions of Other Companies
Sign up for full access to Fulcrum Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Fulcrum Therapeutics and Millions of Other Companies
Sign up for full access to Fulcrum Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. M.
Chief Financial Officer
✕
Access Insights for Fulcrum Therapeutics and Millions of Other Companies
Sign up for full access to Fulcrum Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Fulcrum Therapeutics and Millions of Other Companies
Sign up for full access to Fulcrum Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
H. F.
Chief Regulatory Affairs And Quality Assurance Officer
✕
Access Insights for Fulcrum Therapeutics and Millions of Other Companies
Sign up for full access to Fulcrum Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Fulcrum Therapeutics and Millions of Other Companies
Sign up for full access to Fulcrum Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
I. F.
Interim Chief Medical Officer
✕
Access Insights for Fulcrum Therapeutics and Millions of Other Companies
Sign up for full access to Fulcrum Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Fulcrum Therapeutics and Millions of Other Companies
Sign up for full access to Fulcrum Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Fulcrum Therapeutics

Roche

Editas Medicine

Vertex Pharmaceuticals

Pfizer

Biogen

Solid Biosciences

Fulcrum Therapeutics Tech Stack

Media & News

Fulcrum Therapeutics is developing therapies addressing diseases of high unmet need including pociredir for the treatment of sickle cell disease.

Fulcrum Therapeutics is developing oral losmapimod shone more light on facioscapulohumeral muscular dystrophy.

Fulcrum Therapeutics hired Alan A. Musso as chief financial officer on Aug 7th '23.

Fulcrum Therapeutics partnered with FSHD Society on Jun 20th '23.

Fulcrum Therapeutics is developing therapies to treat Diamond-Blackfan anaemia.

Fulcrum Therapeutics partnered with Camp4tx on Jul 11th '23.

Bronstein, Gewirtz & Grossman, LLC files suit against Fulcrum Therapeutics.

Fulcrum Therapeutics's Email Address Formats

Frequently Asked Questions

Where is Fulcrum Therapeutics's headquarters located?

What is Fulcrum Therapeutics's phone number?

What is Fulcrum Therapeutics's stock symbol?

What is Fulcrum Therapeutics's official website and social media links?

How much revenue does Fulcrum Therapeutics generate?

What is Fulcrum Therapeutics's SIC code NAICS code?

How many employees does Fulcrum Therapeutics have currently?

What industry does Fulcrum Therapeutics belong to?

What technology does Fulcrum Therapeutics use?

What is Fulcrum Therapeutics's email format?

How much funding has Fulcrum Therapeutics raised to date?

When was Fulcrum Therapeutics founded?

Fulcrum Therapeutics

Company Overview

Media & News

Fulcrum Therapeutics is developing therapies addressing diseases of high unmet need including pociredir for the treatment of sickle cell disease.

Fulcrum Therapeutics is developing oral losmapimod shone more light on facioscapulohumeral muscular dystrophy.

Fulcrum Therapeutics hired Alan A. Musso as chief financial officer on Aug 7th '23.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?